These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28491562)

  • 1. Inappropriate shocks by subcutaneous implantable cardioverter-defibrillator due to T-wave oversensing in hyperkalemia leading to ventricular fibrillation.
    Kiamanesh O; O'Neill D; Sivakumaran S; Kimber S
    HeartRhythm Case Rep; 2015 Jul; 1(4):257-259. PubMed ID: 28491562
    [No Abstract]   [Full Text] [Related]  

  • 2. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
    Kooiman KM; Knops RE; Olde Nordkamp L; Wilde AA; de Groot JR
    Heart Rhythm; 2014 Mar; 11(3):426-34. PubMed ID: 24321235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalemia Causing Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks in a Patient with End-Stage Renal Disease: A Case Report and Literature Review.
    Botrus B; Mahtani AU; Isber R; Haider MS; Isber N
    Cureus; 2022 Nov; 14(11):e31137. PubMed ID: 36505168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate Subcutaneous Implantable Cardioverter Defibrillator Shocks Secondary to Cardiac Remodeling: A Unique Case of T Wave Oversensing.
    Saleem M; Pahuja K; Fatima T; Hamilton S; Wjasow C; Fox J
    Cureus; 2022 Jun; 14(6):e26129. PubMed ID: 35875308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.
    Shinohara T; Abe I; Hirota K; Kondo H; Fukui A; Akioka H; Teshima Y; Yufu K; Nakagawa M; Takahashi N
    Heart Vessels; 2021 Feb; 36(2):260-266. PubMed ID: 32833119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of inappropriate implantable cardioverter defibrillator therapy induced by T-wave oversensing due to hyperkalemia.
    Aoki K; Okajima K; Kiuchi K; Yokoi K; Teranishi J; Shimane A
    J Arrhythm; 2015 Dec; 31(6):395-7. PubMed ID: 26702322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T wave oversensing in subcutaneous implantable cardioverter defibrillator secondary to hematoma formation: A potential cause of early postimplantation inappropriate shocks.
    Halawa A; Gautam S
    J Arrhythm; 2019 Feb; 35(1):130-132. PubMed ID: 30805053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis.
    Araújo CS; Silva CLB; da Silva Menezes Júnior A; Barbosa VA; de Almeida Laranjeira T; Fernandes JF; Gonçalves LC; Silva AMC
    Curr Cardiol Rev; 2022; 18(3):e081221198647. PubMed ID: 34879809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new algorithm to reduce inappropriate therapy in the S-ICD system.
    Brisben AJ; Burke MC; Knight BP; Hahn SJ; Herrmann KL; Allavatam V; Mahajan D; Sanghera R; Gold MR
    J Cardiovasc Electrophysiol; 2015 Apr; 26(4):417-423. PubMed ID: 25581303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block.
    Sousa MJ; Betts T
    J Arrhythm; 2017 Feb; 33(1):73-75. PubMed ID: 28217234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate Shocks With Subcutaneous Implantable Cardioverter-Defibrillator in a Young Patient: A Case Report.
    Khan Z; Sethumadhavan D; Rayner T; Kyaw S
    Cureus; 2023 Feb; 15(2):e34492. PubMed ID: 36874347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management.
    Olde Nordkamp LR; Brouwer TF; Barr C; Theuns DA; Boersma LV; Johansen JB; Neuzil P; Wilde AA; Carter N; Husby M; Lambiase PD; Knops RE
    Int J Cardiol; 2015 Sep; 195():126-33. PubMed ID: 26026928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.
    Groh CA; Sharma S; Pelchovitz DJ; Bhave PD; Rhyner J; Verma N; Arora R; Chicos AB; Kim SS; Lin AC; Passman RS; Knight BP
    Heart Rhythm; 2014 Aug; 11(8):1361-6. PubMed ID: 24755323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillator.
    Afzal MR; Evenson C; Badin A; Patel D; Godara H; Essandoh M; Okabe T; Tyler J; Houmsse M; Augostini R; Hummel J; Kalbfleisch S; Daoud EG; Weiss R
    Heart Rhythm; 2017 Oct; 14(10):1436-1439. PubMed ID: 28624663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of electrocardiogram screening during drug challenge test for the prediction of T-wave oversensing by a subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Kamakura T; Wada M; Ishibashi K; Inoue YY; Miyamoto K; Okamura H; Nagase S; Noda T; Aiba T; Yasuda S; Kusano K
    Heart Vessels; 2017 Oct; 32(10):1277-1283. PubMed ID: 28523371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators.
    Hakamata T; Otsuki S; Izumi D; Sakaguchi Y; Suzuki N; Ikami Y; Hasegawa Y; Yagihara N; Iijima K; Chinushi M; Fuse K; Inomata T
    Heart Rhythm; 2022 Oct; 19(10):1704-1711. PubMed ID: 35688344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fully automatic, implantable cardioverter-defibrillator algorithm to prevent inappropriate detection of ventricular tachycardia or fibrillation due to T-wave oversensing in spontaneous rhythm.
    Cao J; Gillberg JM; Swerdlow CD
    Heart Rhythm; 2012 Apr; 9(4):522-30. PubMed ID: 22094074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inappropriate discharges from an intravenous implantable cardioverter defibrillator due to T-wave oversensing.
    Washizuka T; Chinushi M; Kasai H; Watanabe H; Tagawa M; Hosaka Y; Abe A; Aizawa Y
    Jpn Circ J; 2001 Jul; 65(7):685-7. PubMed ID: 11446507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.